Delivery Order SPE2DB22D2211-SPE2DB25FSARV
Award Date 7/11/25
Potential Completion Date 7/14/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 500 MCG TABLET 90S, a prescription medication, with a ceiling value of $6,193.72 and a performance period ending on July 16, 2025. The contract is not set aside and was awarded on July 15, 2025. AmerisourceBergen Drug Corporation holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 500 MCG TABLET 30S, a prescription medication, with a ceiling value of $4,083.75 and a completion date of July 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,059.68, is for the delivery of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price of $5,215.03 and a completion date of June 13, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and the contract is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product, and has a ceiling value of $3,976.29. The contract is a firm fixed price delivery order with a completion date of March 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $1,333.35 and runs through March 25, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,890.98, is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2025 and is a Firm Fixed Price contract. No set-aside designation is mentioned. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALIRESP 500 MCG TABLET 90S. The contract has a firm-fixed price of $25,523.62 and a period of performance through July 9, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product, with a ceiling value of $12,941.28 and a period of performance through May 14, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,335.15, is for the delivery of DALIRESP 500 MCG TABLET 30S. It is a firm fixed-price contract with a completion date of December 30, 2024. The contract is not designated as a set-aside and appears to be an open competition award. AmerisourceBergen holds a significant Indefinite Delivery...